Adjusted EPS Company Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd

Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma

180.00

2002 6.72 1.51 25.22 10.70 37.87 60.21 20.98 29.68 15.58 9.88 6.44 4.24 17.45 15.02 2.25 20.90 10.44 36.43 24.08 167.57

2001 10.78 5.96 32.93 10.56 28.83 45.11 15.69 39.59 11.57 7.18 6.75 7.56 19.81 11.17 13.01 17.59 8.81 27.77 17.16 126.65

2000 24.96 21.02 73.41 6.65 21.91 22.84 45.75 39.07 9.22 10.91 32.11 25.40 15.54 32.23 8.35 30.97 11.60 50.47 16.76 52.63

1999 17.68 23.54 52.63 13.95 57.10 19.26 32.39 31.91 11.13 9.06 153.97 17.37 15.76 23.81 18.81 19.46 22.88 37.10 15.33 135.31

1998 2.28 21.22 50.55 13.35 52.59 22.26 11.88 24.90 8.99 17.15 (5.81) 13.84 24.35 15.64 19.66 17.61 13.19 36.36 18.59 121.62

160.00

140.00

120.00

100.00

80.00

60.00

40.00

20.00

1998 (20.00)

Definition

Formula

Comment:-

Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma

1999

2000

2001

2002

EPS is a small variation of return on equity capital ratio and is calculated by dividing the net profit after taxes and preference dividend by the total number of equity shares. ADJUSTED EPS RATIO = EBIT ADJUSTMENT / NO. OF EQUITY SHARES

From the case, we can analyze that, Ajanta Pharmaceuticals Ltd has been studiedly declining from the year 1998 to 2002 that is from 21.22 to 1.51 by which we can the company is losing its business and in future eventually may undergo to the bankruptcy. On the other side, the company Dr. Reddy's Laboratories show a steady growth from year 1998 to 2002 approximately a growth by 170.49% which is better than other pharma companies. Apart from Dr. Reddy's Laboratories, the companies like Duphar Interfran Ltd, German Remedies Ltd, Glaxo India Ltd, Pfizer Ltd, Torrent Pharmaceuticals Ltd and Zandu Pharmaceuticals Works Ltd also shows a steady growth in the Industry. Zandu Pharmaceuticals Works Ltd shows a higher Earning per share for all the five years indicating a good measure of profitability and shows that the earning power of the company has increased. It can also be analyze that, the pharmacy company like Max India Ltd shows a highest negative slowdown in the industry indicating a negativity of around 210% form the year 1998 to 2002 which also includes other companies like Orchid Chemicals and Pharmaceuticals, Morepen Laboratories Ltd and Aurobindo Pharma Ltd. The company like Sun Pharmaceutical Industries Ltd shows a consistency in the Earning Per Share ratio right from year 1998 to 2002. Max India Ltd shows a great negativity but has improved his performance from year 1998 to 2002 showing a positive sign. Hence, a company giving high Growth fund can be Dr. Reddy's Laboratories and Zandu Pharmaceuticals Works Ltd where as a Consistent return fund can be considered as Sun Pharmaceutical Industries Ltd and Novartis India Ltd.

00 74.00 80.00 64.00 54.50 7.30 5.00 46.00 5.50 5.00 6.50 15.00 18.00 42.00 37.00 3.50 37.00 9.00 4.50 8.00 90.00 1998 Definition Formula Comment .00 5.00 7.50 3.50 7.50 3.00 4.00 92.00 10.00 94.00 5.00 5.00 40.00 6.00 7.00 2.00 98.00 3.00 4.00 5.00 76.00 32.00 5.00 40.00 44.00 5.00 2.00 3.00 56.00 28.00 1.00 7.00 5.00 8.00 4.00 26.50 5.00 3.00 2001 2.00 66.00 78.50 3.50 10.00 3.Dividend Per Share Company Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 1.00 1999 1.00 2.00 24.00 72.00 20.00 50.50 4.00 37.50 3.50 3.00 4.00 1.00 7.00 2.00 5.00 2000 3.00 82.00 3.50 3.00 1998 1.50 2.00 4.50 4.00 14.00 35.00 4.00 3.00 4.50 6.50 4.00 96.00 8.50 3.00 6.00 58.00 84.50 4.00 52.00 2.00 5.00 8.00 22.50 4.25 1.00 5.00 86.50 7.00 7.50 6.00 62.50 28.00 10.50 104.00 5.50 4.00 30.00 68.00 88.00 2.00 34.00 2.50 3.00 5.00 4.00 8.00 5.50 3.00 8.00 60.50 7.00 16.00 36.00 48.00 5.75 3.00 70.50 6.00 12.00 100.00 38.00 2.

.

00 50.00 42.00 70. Dividend Per Share = Dividend paid to ordinary shareholders / Number of equity shares Numb From the data given from the case.00 10.00 20.00 56.00 58.00 86.00 74.00 22.00 66.00 14.00 68.00 2.00 1998 1999 2000 2001 Dividends are a form of profit distribution to the shareholder.00 32.00 62.00 72.00 88.00 54. Having a growing dividend per share can be a sign that the company's management believes that the growth can be sustained.00 40.00 30.00 36.00 6.00 4.00 26.00 84. the company Nicholas Piramal India Ltd shows a stable ratio throughout all the five years.00 52.00 48.00 34. we can analyze that the company including Zandu Pharmaceuticals Works Ltd shows the highest dividend per share ratio for the years apart from the year 1999.00 76.00 46.00 18.00 38.00 90.00 98.00 60.00 8.00 80.00 64.100. Even the company like Novartis India Ltd .00 28.00 94.00 44.00 12.00 96.00 24.00 82. Also.00 92.00 16.00 78.

a company giving high Growth fund can be Zandu Pharmaceuticals Works Ltd where as a Consistent return fund can be considered as Nicholas Piramal India Ltd and Novartis India Ltd. .50 but on the other side it shows a highest fall right after 1999 to 2002 that is from 104. However. return on its sales and provides its profit sharing in the form of if dividend to its shareholder at very highest rate.00 which indicates that the company does not have a good sign of growth and cannot be sustain no longer in the pharmacy industry.50 to 0. Apart from the company like Zandu Pharmaceuticals Works Ltd . a company like Lupin Laboratories and Cadila Healthcare Ltd provides a constant company its shareholder for the last threethat the company earns a healthy Hence.A company like Max India Ltd shows a highest rise from the year 1998 to 1999 that is from 2. whereas the company like Zandu Pharmaceuticals Works Ltd provides the highest dividend to its shareholders. a return to showing a positive sign enables years that from 2000 to 2002.00 to 104.

2001 2002 quity shares Number of equity. .

.

Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 .

24 109.76 54.31 102.87 450.51 108.69 95.04 82.95 1998 14.71 54.02 688.77 224.83 143.98 65.27 79.15 163.65 190.25 89.19 84.35 141.49 106.03 72.32 60.76 2001 72.01 72.49 86.99 81.52 105.41 886.91 119.61 128.80 129.66 219.25 65.27 107.95 254.09 142.90 .94 42.14 225.12 47.51 92.04 113.24 176.27 779.67 168.81 2000 128.10 74.34 42.11 143.16 112.34 135.30 124.18 181.19 90.99 73.72 631.82 536.38 171.19 228.14 79.97 138.13 79.48 64.40 113.55 257.02 114.16 210.14 92.84 67.35 93.87 138.55 174.68 216.19 145.76 104.02 145.93 205.67 52.16 55.79 117.14 83.93 65.63 146.65 84.94 122.47 60.Book Value Company Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 71.37 49.67 204.04 1999 25.34 98.15 37.41 45.91 60.99 95.49 75.38 94.69 82.32 72.72 111.96 206.

874.00 754.00 664.00 814.00 454.00 64.00 544.00 844.00 694.00 Definition Formula Comments .00 154.00 334.00 574.00 634.00 124.00 244.00 724.00 34.00 424.00 214.00 364.00 784.00 184.00 484.00 394.00 304.00 94.00 604.00 514.00 274.

00 784.874. a company giving high Growth fund can be Zandu Pharmaceuticals Works Ltd .00 124. There has been significant increase of approximately 65%.00 544.00 304.00 34.00 94. Lupin Laboratories Ltd shows a high amount of stable The company showing low book value under its Balance Sheet portfolio analysed and cannot be stabilized in the market.00 664. Total Assets less Intangible Assets / No. it can be analysed that the company like Duphar Interfran Ltd.00 634.00 514.00 724.00 244. Dr.00 814.00 1998 1999 2000 2001 The value at which an asset is carried on a balance sheet. Smithkline Beecham Pharmaceuticals . Hence both the pharma On the other side.00 484.00 334.00 574.00 754.00 604. Along with Zandu Pharma Dr.00 64. Ajanta Pharmaceuticals.00 844. we can clearly indicates that the Zandu Pharma Shows a very high growth rate from the year 1998 to 2002.00 394.00 274. of Shares Outstanding From the given data and a graph arrived. Reddy Lab Ltd also shows a very significant growth of around 67%.00 694.00 184.00 214. the company which includes Sun Pharma Industries Ltd.00 154.00 454.00 424. Morepen Laboratories.00 364. Reddy Lab Ltd and Torrent Pharmaceuticals Ltd where as a Consistent .00 4. However.

Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma 2002 .

.

Zandu .

Duphar Abbott Cadila Cipla Glaxo Torrent Smithklin Orchid Morepen Novartis .

16 2001 8.43 18.97 0.44 19.64 13.56) 26.95 14.29 29.08 31.36 31.20 43.66 22.95 23.52 30.77 24.48 15.74 12.09 10.52 22.59 24.88 6.96 28.Return on Net Worth Company Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 8.90 2000 5.37 15.52 34.13 1.23 16.92 1998 (3.10 23.05 21.02 25.57 10.18 6.29 25.88 1999 5.98 9.88 8.29 21.49 0.39 17.62 18.28 14.38 25.58 3.96 30.65 34.90 31.57 15.88 10.95 17.66 29.48 23.86 12.18 14.16 19.07 18.99 11.26 31.67 26.10 27.76 17.74 15.78 17.62 16.97 24.08 20.82 17.15 12.32 19.52 12.91 16.25 15.93 21.72 22.04 93.65 12.60 36.30 2.59 1.51 28.77 7.48 24.45 25.88 22.73 31.43 12.72 26.77 27.84 26.73 16.99 15.06 19.76 .47 26.45 16.08 7.06 37.91 20.63 28.33 16.

00 56.00 (4.00 116.136.00 16.00 96.00 36.00 76.00)1998 Definition Formula Comments .

Aurobindo Pharma Ltd and Orchid Chemicals and Pharmaceuticals turns up to low return provider to its shareholders. But a Company like Abbott laboratories India Ltd which shows a negative return in the year 1998 but therefter it shows a steady growth in the coming four years wherein Companies like Pfizer Ltd . we can analysed that every company shows ups and downs in all the five years. Return on Networth = Net Income / Shareholder's Equity * 100 From the given data.Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 1999 2000 2001 2002 Return on networth is used in the finance as a measure of companies profitability It also reveals that how much profit a company can generates with money that the companies shareholder has invested. Nicholas Piramal India Ltd. . Reddy Laboratories Ltd shows a high growth in the pharmacy industries though the above comapanies where being volatile in the market but there has been significant The companies like Ajanta Pharmaceuticals Ltd . Novartis India Ltd and Dr. It can also be analysed that the company like Sun Phamaceutical Industries Ltd and Cipla Ltd shows a consistant return to its shareholders as per its market share. here it means companies are being volatile in the market.

06 0.57 0.01 0.04 0.01 0.26 0.50 0.68 2.16 0.29 0.18 0.05 0.11 1.34 0.12 0.81 0.10 0.50 1998 Definition Formula Comments .05 0.48 1.45 1.26 0.83 0.03 0.01 0.19 1.50 1.15 1.71 1.04 0.15 0.05 1.11 1.17 0.08 0.44 0.36 0.58 1.24 0.06 0.09 0.05 0.09 0.99 0.21 2.68 0.02 0.15 0.78 2.07 2.07 0.84 1.40 0.34 1.35 0.02 0.25 0.03 1.27 0.31 0.82 0.00 0.90 1.24 0.06 0.71 1.Total Debt/Equity Company Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 2001 2000 1999 1998 0.37 1.30 0.01 0.65 1.03 0.71 1.79 0.48 0.01 1.62 0.04 0.99 1.92 2.03 0.05 0.09 0.01 0.81 0.28 0.00 1.67 0.44 0.04 0.17 0.36 0.84 1.25 0.91 1.56 0.

.

Debt to Equity Ratio = Debt (Liabilities) / Equity The points plotted on the graph with the given data indicates many of the pharma companies shows much ups and down in the industry within the five years spam. Every company except Orchid Chemicals and Pharmaceuticals and Morepen Laboratories Ltd shows positive growth in the year 2002 when compare with the year 1998 A companies like Zandu Pharmaceuticals Works Ltd. Abbott Laboratories and Torrent Pharmaceuticals shows a highest negative towards its Total Debt when compare with its Equity which examines that there is much more liability left unpaid by the companies in a particular year.1999 2000 2001 2002 The debt-to-equity ratio (D/E) is a financial ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. The companies like Pfizer Ltd was much more controllable has the ratio of Total Debts towards Equity was nulifies after the year 1999 .

.We can also examine that if the ratio is more than 2 it can be considered as company would be on higher risky side.

Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma .

64 29.49 57.96 6.78 133.17 2.27 2.22 2001 19.95 3.65 44.16 1.37 2.26 1.74 17.93 2.29 6.28 347.44 2.97 2.78 2.41 35.84 37.16 46.01 120.57 11.05 6.34 1.70 12.64 2.86 7.83 3.44 2.37 103.72 24.54 2.08 14.72 2.44 19.03 7.65 3.92 3.33 1.45 10.09 2.59 115.24 7.26 58.58 3.56 3.26 13.63 68.96 719.68 2.40 1998 1.46 3.57 15.59 38.28 9.69 1999 2.13 82.52 4.55 6.11 3.01 3.11 4.01 20.19 6.17 3.11 2.91 21.95 3.Debt Coverage Ratio Company Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 24.45 2.78 204.40 3.43 2.43 2.82 9.92 2000 6.19 3.37 3.95 6.32 2.28 36.97 27.89 94.80 .94 5.30 82.38 38.10 44.06 7.58 2.95 6.72 18.47 6.56 79.19 3.11 4.72 3.85 6.90 10.

00 302.00 202.702.00 2.00 102.00 602.00 1998 Definition Formula Comments .00 502.00 402.

here there has been very high difference if the same has been compared with the year 2001. The same hike is observed with other comapnies like like Lupin Laboratories Ltd shows a consistency in the ratio for all the The Companies Pfizer Ltd. A company named Pfizer Ltd shows a very high debt coverage ratio from the year . German Remedies Ltd and Dr. Reddy's Laboratories Ltd shows a consistant A company like Smithkline Beecham Pharmaceuticals shows the highest Debt coverage ratio in the year 2002 . spam of five years.1999 2000 2001 2002 Debt Coverage Rato = Profit Before Interest Payment / Fixed Rate Obligation Analysing the data we can intimate that the company like Abbott Laboratories India Ltd. Reddy. Sun Pharmaceuticals Ltd and Dr.s Laboratories Ltd.

Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 .

90 0.74 2.81 4.43 2.91 1.94 3.88 4.15 1.75 3.99 7.32 1.44 2.70 5.60 2.15 0.63 2.77 3.71 3.71 1.38 2.23 5.53 3.96 2.87 0.13 2.11 1.84 4.38 2000 4.99 4.78 2.63 1.12 3.85 3.74 1.24 0.21 4.47 2.45 2.04 2.14 1.71 5.94 1.91 1.51 2.44 2.45 8.66 3.92 5.66 1.03 2.67 2.88 0.21 3.00 2.69 0.Fixed Asset Turnover Ratio Company Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 2001 3.86 .45 2.78 1.46 4.01 3.12 1.25 5.84 1.96 1.74 0.57 1.20 4.90 0.46 2.74 1.69 1.73 1.65 1999 1998 5.35 2.17 0.48 2.18 1.90 4.74 3.79 3.92 0.87 1.74 1.93 1.90 0.08 3.99 2.82 12.78 2.49 1.13 4.75 2.39 10.31 0.11 0.69 0.14 2.54 1.62 1.74 3.

00 4.14.00 10.00 6.00 1998 Definition Formula Comments .00 2.00 12.00 8.

Sun Pharmaceuticals India Ltd shows a better turnover ratio as compared to other Pharmaceuticals companies On the other hand the companies like Novartis India Ltd.Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 1999 2000 2001 2002 Fixed Asset Turnover ratio provides how much retun on Investment is achived during a particular period. Through this ratio we can even compare the profit margin of different companies within the same Industry. Max India Ltd . Dr. Cadila Healthcare Ltd . the companies like Nicholas Priramal India Ltd. German Remedies Ltd . Reddy's Laboratories Ltd and Abbott laboratories India Ltd shows a stable turnover ratio under the spam of five years The companies like Ajanta Phamarceuticals Ltd. Fixed Asset Turnover Ratio = Sales Revenue / Fixed Assets It has been observed that many of the above pharma companies are stable under above data of Fixed Asset Turnover Ratio However. Smithkline Beecham Pharmaceuticals Ltd and Zandu Pharmaceuticals Ltd shows a very low turnover ratio when compared with the years between 1998 to . Duphar Interfan Ltd . Cipla Ltd .

.

08 46.54 14.72 14.74 16.83 6.00 8.71 15.14 6.46 2000 3.64 9.84 9.99 1.30 31.99 5.03 52.94 4.72 2001 5.49 7.34 6.53 65.42 2.55 9.17 49.12 8.15 1.92 0.08 13.23 7.20 37.84 32.66 3.17 35.09 6.22 5.81 0.80 8.83 1998 1.66 12.36 30.55 0.94 12.29 5.42 30.77 24.41 7.69 13.28 53.97 7.02 18.76 1.33 33.19 1.28 84.22 8.03 31.05 6.Exports as per cent of Total Sales Company Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma 2002 7.35 40.31 35.60 12.19 4.00 57.81 54.39 36.38 14.90 0.22 9.80 20.47 6.32 26.53 28.71 0.78 42.29 89.52 35.22 7.61 27.88 0.00 .49 1.17 9.69 12.73 9.07 38.17 1.56 20.38 1999 2.16 10.45 19.00 20.40 88.01 6.54 31.57 31.04 0.22 86.77 100.07 8.23 6.35 90.

.

100.00 30.00 60.00 70.00 10.00 1998 Definition Formula Comments .00 20.00 80.00 40.00 90.00 50.

.

But there is consitence ratio main towrds that particular period.1999 2000 2001 2002 Export Turnover Ratio towards Total Sales provides the how company spreads its market share. It can also provide how company generates its Revenue towards its sales in foreign countries Export Turnover Ratio = Export Sales / Total Revenue (Sales) From the data. Cadila Healthcare Ltd and even Zandu Pharmacceuticals has overcome with a consisitant growth for the last three years . However apart from Orchid Chemicals and Pharmaceuticals Ltd other companies also show a stable ratio like Sun Pharmaceuticals India Ltd . Aurobindo Pharma Ltd. It has been observed that the only Company named Orchid Chemicals and Paharmaceuticals shows the highest export turnover for all the spam of five years. Ajanta Pharmaceuticals Ltd.

On the Other side there has been significant growth in Export Turnover Ratio for the companies like Abbott Laboratories India Ltd though it has been on lower side with other pharmaceuticals companies but has shown a growth of approxiemetly of 288% when comapred from the year 1998 to 2002. Apart from Abbott Laboratories India Ltd a company name Cipla Ltd has also shown a significant growth of around 153% over the spam of five years .

Abbott Lab I Ltd Ajanta Pharma Ltd Aurobindo Pharma Ltd Cadila Healthcare Ltd Cipla Ltd Dr Reddys Lab Ltd Duphar Int Ltd German Remedies Ltd Glaxo India Ltd Lupin Lab Ltd Max India Ltd Morepen Lab Ltd Nicholas Piramal I Ltd Novartis I Ltd Orchid Chem & Pharma Pfizer India Smithkline Bec Pharma Sun Pharma Ind Ltd Torrent Pharma Zandu Pharma .

Comments .

Max India Ltd and Novartis India Ltd has shown a consistent return . the other pharma companies like Sun Phamaceuticals Industries Ltd and Cipla Ltd have also We can also conclude that the Zandu Pharmaceuticals Works Ltd . Reddy's Laboratories Ltd perfomance in all the ratio is well maintained and it has shown a Apart from Dr.From above all the data provided for all twenty Pharmaceuticlas companies and when compared with all the ratios provided and as per graphical analysis it has been observed that Dr. Reddy's laboaratories Ltd.

Sign up to vote on this title
UsefulNot useful